Ainos Inc Stock Today

AIMDW Stock  USD 0.05  0  3.61%   

Performance

27 of 100

 
Weak
 
Strong
Strong

Odds Of Distress

Over 51

 
High
 
Low
Average
Ainos is selling for under 0.048 as of the 11th of October 2024; that is 3.61% down since the beginning of the trading day. The stock's lowest day price was 0.042. Ainos has 51 percent odds of going through some form of financial distress in the next two years but had a very strong returns during the last 90 days. Equity ratings for Ainos Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 11th of September 2024 and ending today, the 11th of October 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
9th of August 2022
Category
Healthcare
Classification
Health Care
Ainos, Inc., a healthcare company, engages in the developing medical technologies for point-of-care testing and safe and novel medical treatment for disease indications. Ainos, Inc. was incorporated in 1984 and is based in San Diego, California. Ainos Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. More on Ainos Inc

Moving against Ainos Stock

  0.73DNLI Denali TherapeuticsPairCorr
  0.63VERA Vera TherapeuticsPairCorr
  0.58VCYT VeracytePairCorr
  0.57DRTS Alpha Tau MedicalPairCorr
  0.54DMAC DiaMedica TherapeuticsPairCorr
  0.4A Agilent Technologies Fiscal Year End 18th of November 2024 PairCorr

Ainos Stock Highlights

President BoardChunHsien Tsai
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors)
Financial Strength
Current ValueLast YearChange From Last Year 10 Year Trend
Asset Turnover0.00360.0038
Notably Down
Slightly volatile
Total Current Liabilities1.3 M1.3 M
Notably Down
Pretty Stable
Non Current Liabilities Total6.4 M6.1 M
Sufficiently Up
Slightly volatile
Total Assets33.4 M31.8 M
Sufficiently Up
Slightly volatile
Total Current Assets2.6 M2.5 M
Sufficiently Up
Slightly volatile
Ainos can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Ainos' financial leverage. It provides some insight into what part of Ainos' total assets is financed by creditors.
Liquidity
Ainos Inc has accumulated 5.96 M in total debt with debt to equity ratio (D/E) of 3.87, implying the company greatly relies on financing operations through barrowing. Ainos Inc has a current ratio of 0.52, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Note, when we think about Ainos' use of debt, we should always consider it together with its cash and equity.

End Period Cash Flow

1.98 Million
Ainos Inc (AIMDW) is traded on NASDAQ Exchange in USA. It is located in 8880 Rio San Diego Drive, San Diego, CA, United States, 92108 and employs 46 people. Ainos is listed under Biotechnology category by Fama And French industry classification. The company classifies itself under Biotechnology sector and is part of Health Care industry. Ainos Inc has accumulated about 1.87 M in cash with (4.69 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.19, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Ainos Probability Of Bankruptcy

Ainos Historical Income Statement

At this time, Ainos' Depreciation And Amortization is fairly stable compared to the past year. Interest Expense is likely to climb to about 234.1 K in 2024, despite the fact that Gross Profit is likely to grow to (4.9 M). View More Fundamentals

Ainos Stock Against Markets

Ainos Corporate Management

HuiLan WuChief OfficerProfile
HsinLiang LeeChief OfficerProfile
Lawrence LinExecutive OperationsProfile
MengLin SungChief OfficerProfile
John EsqCorp CounselProfile

Already Invested in Ainos Inc?

The danger of trading Ainos Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Ainos is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Ainos. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Ainos Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.

Additional Tools for Ainos Stock Analysis

When running Ainos' price analysis, check to measure Ainos' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ainos is operating at the current time. Most of Ainos' value examination focuses on studying past and present price action to predict the probability of Ainos' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ainos' price. Additionally, you may evaluate how the addition of Ainos to your portfolios can decrease your overall portfolio volatility.